• Explore /
  • Poster
  • / Polymorphism in the circadian clock pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from TRIBE and FIRE-3 phase III trials.

Polymorphism in the circadian clock pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from TRIBE and FIRE-3 phase III trials.

Abstract Poster

Authors

Francesca Battaglin

Francesca Battaglin

Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA

Francesca Battaglin , Shu Cao , Joshua Millstein , Alberto Puccini , Ryuma Tokunaga , Madiha Naseem , Shivani Soni , Michelle McSkane , Martin D. Berger , Afsaneh Barzi , Wu Zhang , Vittorina Zagonel , Chiara Cremolini , Sebastian Stintzing , Fotios Loupakis , Alfredo Falcone , Volker Heinemann , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3576)

DOI

10.1200/JCO.2018.36.15_suppl.3576

Abstract #

3576

Poster Bd #

69

Abstract Disclosures

Similar Posters

First Author: Francesca Battaglin

First Author: Madiha Naseem

First Author: Alberto Puccini

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).

Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).

First Author: Karam Ashouri